Rate of incident MACE per 100 patient years by average achieved on-treatment LDL-D levels in patients with ASCVD with and without comorbidities in a pooled analysis of alirocumab Phase 3a trials.
CCBs: Calcium Channel Blockers; RAS: Renin-angiotensin system. *Some patients were lost to follow-up or withdrew, and the rate of lost to follow-up was not significantly different between the two grou
Abstract INTRODUCTION: Chronic chagasic cardiopathy (CCC) is essentially a dilated cardiomyopathy in which a subacute, but constant chronic inflammatory process causes progressive destruction of the h
Background: This study aims to explore the role of low-dose rivaroxaban (≤10 mg daily) for the treatment of atherosclerotic cardiovascular disease (ASCVD). Methods: PubMed, Embase and the Cochrane Lib
